-

Shareholder Alert: Robbins LLP Reminds Investors RTI Surgical Holdings, Inc. (RTIX) Sued for Misleading Shareholders

SAN DIEGO & DEERFIELD, Ill.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of RTI Surgical Holdings, Inc. (NASDAQ: RTIX) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between March 7, 2016 and March 16, 2020. RTI is a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide.

If you suffered a loss as a result of RTI's misconduct, click here.

RTI Surgical Holdings, Inc. (RTIX) Accused of Misleading Shareholders

According to the complaint, from 2016 to 2019, RTI continuously attested to its accuracy of financial reporting, disclosure of any material changes to its internal controls over financial reporting, and disclosure of all fraud. Regarding its revenue recognition, in January 2018, RTI assured investors that its results after adopting the new amended accounting standards implemented by the Financial Accounting Standards Board in 2016 were "substantially consistent with the Company's current revenue recognition policies" and RTI did not expect a material impact on its financial position when recognizing revenue from its current contracts with the new standard. Despite assurances, on March 16, 2020, RTI announced that it would be unable to timely file its Form 10-K for fiscal year 2019, citing an internal investigation of the Company's revenue recognition practices by its Audit Committee. RTI disclosed that its internal investigation had been precipitated by an SEC investigation related to the periods 2014 through 2016. On this news, shares of RTI fell over 14% to close at $2.35. The stock continues to decline.

RTI Surgical Holdings, Inc. (RTIX) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:RTIX

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges Investors Who Lost Money Investing in Upstart Holdings, Inc. to Contact the Firm for Information About Leading the Class Action Against UPST

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Upstart Holdings, Inc. (NASDAQ: UPST) securities between May 14, 2025 and November 4, 2025. Upstart, together with its subsidiaries, operates a cloud-based artificial intelligence (“AI”) lending platform in the U.S.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period?...

Robbins LLP Urges Investors Who Lost Money Investing in Stellantis N.V. to Contact the Firm for Information About Leading the Class Action Against STLA

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Stellantis N.V. (NYSE: STLA) securities between February 26, 2025 and February 5, 2026. Stellantis is a global automobile designer, engineer, manufacturer, and distributor.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period? February 26, 2025 – February 5, 2026What a...

Robbins LLP Urges Investors Who Lost Money Investing in Medpace Holdings Inc. to Contact the Firm for Information About Leading the Class Action Against MEDP

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22, 2025 and February 9, 2026. Medpace is a clinical contract research organization (CRO) focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.For more information, submit a form, email...
Back to Newsroom